The authors focus on the mechanisms of epigenetic modifications occurring to the pivotal tumor microenvironment (TME) components including the stroma, immune and myeloid cells in various tumors reported in the last five years, concluding the tight correlation between TME reprogramming and tumor progression and immunosuppression.
[Molecular Biomedicine]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News